General Information of Drug (ID: DMP2U95)

Drug Name
AGS-004
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus-1 infection 1C62 Phase 2 [1]
Cross-matching ID
TTD ID
D04ZZT

References

1 ClinicalTrials.gov (NCT01069809) Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption. U.S. National Institutes of Health.